TFX Teleflex Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: TFX
  4. Earnings
Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 76

EPS in 2026 (TTM): $8.32

Last Report Period Date: Sep 30, 2026

Based on the company's latest reports for September 2026, the current 12-month EPS is $8.32. Teleflex's earnings per share in 2025 was reported at -$20.3, marking a decline from $1.49 in 2024. In the quarterly report ending on Sep 30, 2026, TFX's earnings per share amounted to $22.36.

TFX earnings history

Historical annual and quarterly earnings per share (EPS) data for Teleflex
EPS (TTM)
$8.32
EPS Growth YoY (Quarterly)
342%
EPS (Quarterly)
$22.36
EPS Growth (Quarterly)
876.4%

Teleflex had an yealy earnings per share of -$20.3, showing a decline of 1,462.4% from $1.49 recorded in 2024. The quarterly earnings per share for the period ending Sep 30, 2026, was $22.36, showing a 342% increase compared to the same quarter last year. The trailing twelve months EPS for TFX is $8.32 as of September 2026. Teleflex's full-year EPS for 2024 was $1.49, a 80.3% decline compared to the previous year.

TFX EPS vs price chart

TFX EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
342%
EPS growth YoY
-1,462.4%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

Teleflex has recorded a growth in earnings per share of 342% in the past 12 months (YoY, quarterly).

TFX Earnings Waterfall

Breakdown of revenue, profit and net income for Teleflex

TFX Earnings vs Peers

What are the earnings of TFX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
TFX Teleflex Incorporated 18.48 -1,462.4% N/A N/A
BSX Boston Scientific Corp 18.59 55.6% 63.3% N/A
COO Cooper Companies Inc 21.2 -4.6% -1.2% 9.2%
MMSI Merit Medical Systems Inc 32.23 4.8% 18.3% N/A
GE General Electric Company 38.19 35.8% 447.4% 12.1%
JNJ Johnson & Johnson 42.62 90.6% 17.7% 14.8%
BDX Becton Dickinson & Company 64.88 -0.9% -0.6% 16.2%
IART Integra Lifesciences Holdings Corp 83.91 -7,388.9% N/A N/A
ANGO Angiodynamics Inc N/A -6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.